340 related articles for article (PubMed ID: 2153235)
21. Topoisomerase II cleavage of herpes simplex virus type 1 DNA in vivo is replication dependent.
Ebert SN; Shtrom SS; Muller MT
J Virol; 1990 Sep; 64(9):4059-66. PubMed ID: 2166804
[TBL] [Abstract][Full Text] [Related]
22. Exposure to camptothecin breaks leading and lagging strand simian virus 40 DNA replication forks.
Shin CG; Snapka RM
Biochem Biophys Res Commun; 1990 Apr; 168(1):135-40. PubMed ID: 2158312
[TBL] [Abstract][Full Text] [Related]
23. Altered topoisomerase I and II activities in suramin-resistant lung fibrosarcoma cells.
Lelièvre S; Benchokroun Y; Larsen AK
Mol Pharmacol; 1995 May; 47(5):898-906. PubMed ID: 7746278
[TBL] [Abstract][Full Text] [Related]
24. Autonomous parvovirus DNA replication requires topoisomerase I and its activity is increased during infection.
Gu ML; Rhode SL
J Virol; 1991 Mar; 65(3):1662-5. PubMed ID: 1847484
[TBL] [Abstract][Full Text] [Related]
25. Topoisomerase inhibitors induce irreversible fragmentation of replicated DNA in concanavalin A stimulated splenocytes.
Jaxel C; Taudou G; Portemer C; Mirambeau G; Panijel J; Duguet M
Biochemistry; 1988 Jan; 27(1):95-9. PubMed ID: 2831966
[TBL] [Abstract][Full Text] [Related]
26. Nascent DNA Proteomics Reveals a Chromatin Remodeler Required for Topoisomerase I Loading at Replication Forks.
Ribeyre C; Zellweger R; Chauvin M; Bec N; Larroque C; Lopes M; Constantinou A
Cell Rep; 2016 Apr; 15(2):300-9. PubMed ID: 27050524
[TBL] [Abstract][Full Text] [Related]
27. TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II.
Barthelmes HU; Habermeyer M; Christensen MO; Mielke C; Interthal H; Pouliot JJ; Boege F; Marko D
J Biol Chem; 2004 Dec; 279(53):55618-25. PubMed ID: 15494395
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a camptothecin-resistant human DNA topoisomerase I in an in vitro system for Simian virus 40 DNA replication.
Ishimi Y; Nishizawa M; Andoh T
Eur J Biochem; 1991 Dec; 202(3):835-9. PubMed ID: 1662615
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and evaluation of novel ellipticines as potential anti-cancer agents.
Deane FM; O'Sullivan EC; Maguire AR; Gilbert J; Sakoff JA; McCluskey A; McCarthy FO
Org Biomol Chem; 2013 Feb; 11(8):1334-44. PubMed ID: 23314103
[TBL] [Abstract][Full Text] [Related]
30. ATP-independent DNA topoisomerase II as potential drug target in trypanosomes.
Douc-Rasy S; Riou JF; Ahomadegbe JC; Riou G
Biol Cell; 1988; 64(2):145-56. PubMed ID: 2852517
[TBL] [Abstract][Full Text] [Related]
31. DNA topoisomerases as targets for the anticancer drug TAS-103: primary cellular target and DNA cleavage enhancement.
Byl JA; Fortune JM; Burden DA; Nitiss JL; Utsugi T; Yamada Y; Osheroff N
Biochemistry; 1999 Nov; 38(47):15573-9. PubMed ID: 10569941
[TBL] [Abstract][Full Text] [Related]
32. [Inhibition by ellipticine derivatives of the reactions catalysed by the topoisomerases: preferential inhibition of topoisomerase II].
Douc-Rasy S; Multon E; Kayser A; Riou G
C R Seances Acad Sci III; 1983; 296(19):899-904. PubMed ID: 6311366
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of topoisomerase II by ICRF-193 prevents efficient replication of herpes simplex virus type 1.
Hammarsten O; Yao X; Elias P
J Virol; 1996 Jul; 70(7):4523-9. PubMed ID: 8676478
[TBL] [Abstract][Full Text] [Related]
34. WRN protects against topo I but not topo II inhibitors by preventing DNA break formation.
Christmann M; Tomicic MT; Gestrich C; Roos WP; Bohr VA; Kaina B
DNA Repair (Amst); 2008 Dec; 7(12):1999-2009. PubMed ID: 18805512
[TBL] [Abstract][Full Text] [Related]
35. Topoisomerase II plays an essential role as a swivelase in the late stage of SV40 chromosome replication in vitro.
Ishimi Y; Sugasawa K; Hanaoka F; Eki T; Hurwitz J
J Biol Chem; 1992 Jan; 267(1):462-6. PubMed ID: 1309747
[TBL] [Abstract][Full Text] [Related]
36. DNA topoisomerase inhibitors as antifungal agents.
Shen LL; Fostel JM
Adv Pharmacol; 1994; 29B():227-44. PubMed ID: 8996610
[No Abstract] [Full Text] [Related]
37. Camptothecin, a specific inhibitor of type I DNA topoisomerase, induces DNA breakage at replication forks.
Avemann K; Knippers R; Koller T; Sogo JM
Mol Cell Biol; 1988 Aug; 8(8):3026-34. PubMed ID: 2850477
[TBL] [Abstract][Full Text] [Related]
38. Topoisomerase inhibitors can selectively interfere with different stages of simian virus 40 DNA replication.
Snapka RM
Mol Cell Biol; 1986 Dec; 6(12):4221-7. PubMed ID: 3025645
[TBL] [Abstract][Full Text] [Related]
39. Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA:DNA-PK complexes.
Shao RG; Cao CX; Zhang H; Kohn KW; Wold MS; Pommier Y
EMBO J; 1999 Mar; 18(5):1397-406. PubMed ID: 10064605
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of potentially lethal and sublethal damage repair by camptothecin and etoposide in human melanoma cell lines.
Ng CE; Bussey AM; Raaphorst GP
Int J Radiat Biol; 1994 Jul; 66(1):49-57. PubMed ID: 8027612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]